Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Ma, Liang ^a,b   Wen, Zhe Sheng ^c   Liu, Zi ^a   Hu, Zheng ^d   Ma, Jun ^c   Chen, Xiao Qin ^c   Liu, Yong Qiang ^a   Pu, Jian Xin ^e   Xiao, Wei Lie ^e   Sun, Han Dong ^e   Zhou, Guang Biao ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^e KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCEROUS INHIBITOR OF PP2A; ONCOPROTEIN; RABDOCOETSIN B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; AUTOANTIGEN; DITERPENE; KIAA1524 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CIGARETTE SMOKING; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; RABDOSIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; DRUG EFFECT; GENETICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG TUMOR; METABOLISM; SMOKING; TUMOR CELL LINE;

RABDOSIA;

AUTOANTIGENS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING;

EID: 79957864490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020159     Document Type: Article

References (29)

1. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, et al. (2007) Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society, 2007. Available:http://www.cancer.org/Research/CancerFactsFigures/GlobalCancerFactsFigures/global-cancer-facts-figures-2007.
2. Herbst RS, Heymach JV, Lippman SM, (2008) Lung Cancer. N Engl J Med 359: 1367-1380.
3. Junttila MR, Puustinen P, Niemela M, Ahola R, Arnold H, et al. (2007) CIP2A inhibits PP2A in human malignancies. Cell 130: 51-62.
4. Khanna A, Bockelman C, Hemmes A, Junttila MR, Wiksten JP, et al. (2009) MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst 101: 793-805.
5. Li W, Ge Z, Liu C, Liu Z, Bjorkholm M, et al. (2008) CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res 14: 3722-3728.
6. Come C, Laine A, Chanrion M, Edgren H, Mattila E, et al. (2009) CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 15: 5092-5100.
7. Soo HL, Zhang JY, Chan EK, (2002) Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene 21: 5006-5015.
8. Zhou GB, Ma L, Wen ZS, (2010) Cancerous inhibitor of phosphatase PP2A in lung cancer. AACR 101st Annual Meeting 2010 in Washington, DC Permanent Abstract Number.
9. Sharma SV, Bell DW, Settleman J, Haber DA, (2007) Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7: 169-181.
10. Hecht SS, (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3: 461-469.
11. Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, et al. (2010) The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 120: 521-532.
12. Hu Z, Pan XF, Wu FQ, Ma LY, Liu DP, et al. (2009) Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia. PLoS ONE 4: e6257.
13. Feng T, Pu J, Hu Z, Liu D, Sun H, et al. (2009) Rabdocoetsin B, a diterpenoid isolated from Isodon coetsa, is a potential proteasome inhibitor and induced apoptosis of t(8;21) leukemia cells. Chin J Biotech 25: 1218-1224.
14. Chen YP, Sun HD, Lin ZW, (2011) Study on the diterpenoids of Rabdosia coetsa. Acta Bot Sin 32: 292-296.
15. Chen KF, Liu CY, Lin YC, Yu HC, Liu TH, et al. (2010) CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Oncogene 29: 6257-6266.
16. Brognard J, Clark AS, Ni Y, Dennis PA, (2001) Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61: 3986-3997.
17. David O, Jett J, LeBeau H, Dy G, Hughes J, et al. (2004) Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. Clin Cancer Res 10: 6865-6871.
18. Basile JR, Czerninski R, (2010) The role of CIP2A in oral squamous cell carcinoma. Cancer Biol Ther 10: 700-702.
19. Vaarala M, Vaisanen MR, Ristimaki A, (2010) CIP2A expression is increased in prostate cancer. Journal of Experimental & Clinical Cancer Research 29: 136.
20. Qu W, Li W, Wei L, Xing L, Wang X, et al. (2010) CIP2A is overexpressed in esophageal squamous cell carcinoma. Medical Oncology pp. 1-6.
21. Wang J, Li W, Li L, Yu X, Jia J, et al. (2011) CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation. Int J Lab Hematol doi 10.1111/j.1751-553X.2010.01288.x. [Epub ahead of print].
22. Peng B, Liu SS, Qian W, Chan EKL, Tan EM, et al. (2010) Immune response to a fetal oncoprotein p90/CIP2A in lung cancer. AACR 101 Annual Meeting Abstract Book Abstract # 4792.
23. Dong QZ, Wang Y, Dong XJ, Li ZX, Tang ZP, et al. (2010) CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis. Annals of Surgical Oncology pp. 1-9.
24. Yang G, Fan L, Tan J, Qi G, Zhang Y, et al. (1999) Smoking in China. JAMA: The Journal of the American Medical Association 282: 1247-1253.
25. Gu D, Kelly TN, Wu X, Chen J, Samet JM, et al. (2009) Mortality Attributable to Smoking in China. New England Journal of Medicine 360: 150-159.
26. Jha P, (2009) Avoidable global cancer deaths and total deaths from smoking. Nature Reviews Cancer 9: 655-664.
27. Zhao D, Liu Z, Ding J, Li W, Sun Y, et al. (2010) Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. J Med Microbiol 59: 259-265.
28. Wang YY, Zhou GB, Yin T, Chen B, Shi JY, et al. (2005) AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci U S A 102: 1104-1109.
29. Remmele W, Stegner HE, (1987) [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8: 138-140.